EXEL Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 2.60%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $37,028,704.88

Exelixis Insider Trading History Chart

Exelixis Share Price & Price History

^$51.91

▼ -0.53 (-1.01%)

As of 06/18/2026 04:00 PM ET

Days: 30 | 90 | 365

Exelixis Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/1/2026	Jack L Wyszomierski	Director	Sell	3,925	$50.55	$198,408.75	284,384
6/1/2026	Sue Gail Eckhardt	Director	Sell	9,812	$50.14	$491,973.68	16,079
5/26/2026	Dana Aftab	EVP	Sell	43,451	$50.35	$2,187,757.85	594,741
5/20/2026	Patrick J Haley	EVP	Sell	32,110	$49.81	$1,599,399.10	357,638
5/18/2026	Brenda Hefti	SVP	Sell	6,625	$50.21	$332,641.25	106,762
5/18/2026	Christopher J Senner	CFO	Sell	34,901	$50.00	$1,745,050.00	952,317
5/7/2026	George Poste	Director	Sell	60,000	$45.71	$2,742,600.00	118,832
5/7/2026	Maria C. Freire	Director	Sell	20,634	$46.00	$949,164.00	100,819
5/7/2026	Mary C Beckerle	Director	Sell	7,712	$48.45	$373,646.40	17,524
2/24/2026	Dana Aftab	EVP	Sell	47,918	$44.50	$2,132,351.00	616,106
2/19/2026	Dana Aftab	EVP	Sell	29,873	$44.35	$1,324,867.55	664,024
2/18/2026	Brenda Hefti	SVP	Sell	18,669	$44.01	$821,622.69	96,512
2/18/2026	Jack L Wyszomierski	Director	Sell	99,574	$44.01	$4,382,251.74	279,942
2/17/2026	Christopher J Senner	CFO	Sell	30,617	$43.67	$1,337,044.39	976,092
2/17/2026	Patrick J Haley	EVP	Sell	67,814	$43.52	$2,951,265.28	381,908
2/13/2026	Bob Oliver	Director	Sell	30,250	$43.81	$1,325,252.50	21,120
2/13/2026	Christopher J Senner	CFO	Sell	34,278	$43.00	$1,473,954.00	1,042,579
2/13/2026	Sue Gail Eckhardt	Director	Sell	3,856	$43.79	$168,854.24	17,524
11/21/2025	Patrick J Haley	EVP	Sell	28,043	$42.58	$1,194,070.94	374,029
11/20/2025	Patrick J Haley	EVP	Sell	10,000	$42.11	$421,100.00	402,072
11/20/2025	Patrick J Haley	EVP	Sell	34,187	$41.88	$1,431,751.56
11/12/2025	Stelios Papadopoulos	Director	Sell	100,000	$43.55	$4,355,000.00	1,189,228
11/11/2025	Dana Aftab	EVP	Sell	48,383	$42.50	$2,056,277.50	664,778
11/11/2025	Mary C Beckerle	Director	Sell	24,622	$41.93	$1,032,400.46	21,380
6/3/2025	Jack L Wyszomierski	Director	Sell	7,535	$43.09	$324,683.15	358,882
6/2/2025	Sue Gail Eckhardt	Director	Sell	18,838	$42.74	$805,136.12	21,380
5/21/2025	Tomas J. Heyman	Director	Sell	4,544	$44.29	$201,253.76	32,470
5/20/2025	Patrick J Haley	EVP	Sell	34,387	$44.06	$1,515,091.22	412,072
5/16/2025	Amy C Peterson	CMO	Sell	72,776	$45.47	$3,309,124.72	465,393
5/16/2025	Christopher J Senner	CFO	Sell	100,000	$46.00	$4,600,000.00	967,842
5/16/2025	George Poste	Director	Sell	20,634	$45.99	$948,957.66	169,020
5/15/2025	Jeffrey J. Hessekiel	EVP	Sell	25,000	$46.18	$1,154,500.00	693,396
5/15/2025	Patrick J Haley	EVP	Sell	126,383	$47.96	$6,061,328.68	446,459
5/15/2025	Stelios Papadopoulos	Director	Sell	36,508	$44.35	$1,619,129.80	1,279,416
5/14/2025	Patrick J Haley	EVP	Sell	10,000	$42.68	$426,800.00	491,164
5/1/2025	Dana Aftab	EVP	Sell	1,508	$39.00	$58,812.00	693,181
3/3/2025	Patrick J Haley	EVP	Sell	10,000	$38.80	$388,000.00	341,028
2/28/2025	Jack L Wyszomierski	Director	Sell	8,768	$37.80	$331,430.40	356,605
2/28/2025	Jack L Wyszomierski	Director	Sell	8,768	$37.80	$331,430.40	356,605
2/25/2025	Bob Oliver	Director	Sell	18,647	$37.25	$694,600.75	33,514
2/24/2025	Christopher J Senner	CFO	Sell	29,314	$36.14	$1,059,407.96	779,607
2/24/2025	Patrick J Haley	EVP	Sell	52,636	$36.98	$1,946,479.28	303,310
2/14/2025	Mary C Beckerle	Director	Sell	12,210	$34.88	$425,884.80	30,406
11/29/2024	Jeffrey J. Hessekiel	EVP	Sell	60,000	$36.67	$2,200,200.00	486,059
11/22/2024	Patrick J Haley	EVP	Sell	10,000	$35.27	$352,700.00	278,665
11/18/2024	Patrick J Haley	EVP	Sell	41,588	$34.36	$1,428,963.68	288,665
11/5/2024	Dana Aftab	EVP	Sell	96,986	$35.00	$3,394,510.00	498,945
11/1/2024	George Poste	Director	Sell	30,000	$34.00	$1,020,000.00	169,020
11/1/2024	Jeffrey J. Hessekiel	EVP	Sell	50,000	$34.13	$1,706,500.00	530,325
10/30/2024	Dana Aftab	EVP	Sell	1,162	$31.40	$36,486.80	498,945
10/28/2024	Jeffrey J. Hessekiel	EVP	Sell	25,000	$28.39	$709,750.00	580,325
9/23/2024	Jeffrey J. Hessekiel	EVP	Sell	25,000	$26.38	$659,500.00	605,325
8/26/2024	Jeffrey J. Hessekiel	EVP	Sell	20,000	$25.79	$515,800.00	630,325
8/14/2024	Maria C. Freire	Director	Sell	8,250	$26.56	$219,120.00	91,007
8/12/2024	Dana Aftab	EVP	Sell	20,883	$27.06	$565,093.98	500,107
8/9/2024	Christopher J Senner	CFO	Sell	125,000	$27.19	$3,398,750.00	721,680
8/8/2024	George Poste	Director	Sell	33,725	$26.89	$906,865.25	199,020
8/7/2024	Dana Aftab	EVP	Sell	95,000	$25.00	$2,375,000.00	520,990
6/4/2024	Jack L Wyszomierski	Director	Sell	8,287	$22.00	$182,314.00	349,499
5/30/2024	David Edward Johnson	Director	Buy	225,000	$20.76	$4,671,000.00	1,525,730
5/28/2024	David Edward Johnson	Director	Buy	200,000	$20.32	$4,064,000.00	1,300,730
5/21/2024	George Poste	Director	Sell	11,686	$20.96	$244,938.56	213,907
5/13/2024	Jack L Wyszomierski	Director	Sell	10,923	$21.37	$233,424.51	338,948
3/21/2024	Alan M. Garber	Director	Sell	19,205	$24.01	$461,112.05	35,703
2/23/2024	Patrick J Haley	EVP	Sell	47,020	$21.45	$1,008,579.00	384,866
2/21/2024	David Edward Johnson	Director	Buy	190,000	$20.70	$3,933,000.00	1,100,730
12/14/2023	Patrick J Haley	EVP	Sell	50,000	$23.35	$1,167,500.00	307,687
12/12/2023	Patrick J Haley	EVP	Sell	14,149	$22.50	$318,352.50	307,687
12/4/2023	Jeffrey J. Hessekiel	EVP	Sell	25,000	$22.06	$551,500.00	558,345
11/30/2023	Jeffrey J. Hessekiel	EVP	Sell	25,000	$22.01	$550,250.00	583,345
11/27/2023	David Edward Johnson	Director	Buy	120,409	$21.61	$2,602,038.49	910,730
8/30/2023	Dana Aftab	EVP	Sell	4,600	$22.47	$103,362.00	399,943
8/3/2023	Christopher J Senner	CFO	Sell	60,000	$20.51	$1,230,600.00	571,631
8/3/2023	Patrick J Haley	EVP	Sell	30,553	$20.67	$631,530.51	285,467
8/1/2023	Jeffrey J. Hessekiel	EVP	Sell	55,710	$19.63	$1,093,587.30	571,976

SEC Filings (Institutional Ownership Changes) for Exelixis (NASDAQ:EXEL)

85.27% of Exelixis stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Exelixis Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
6/18/2026	Pacer Advisors Inc.	1,549,611	$66.46M	0.1%	+24.9%	0.617%
6/3/2026	Parallel Advisors LLC	9,115	$0.39M	0.0%	+5.7%	0.004%
6/3/2026	NewEdge Advisors LLC	33,985	$1.46M	0.0%	-9.8%	0.014%
6/1/2026	Caerus Investment Advisors LLC	7,661	$0.33M	0.1%	-56.6%	0.003%
5/29/2026	Ramiah Investment Group	5,238	$0.23M	0.2%	N/A	0.002%
5/26/2026	Glenmede Trust Co. NA	8,217	$0.35M	0.0%	+10.1%	0.003%
5/22/2026	Segall Bryant & Hamill LLC	6,729	$0.28M	0.0%	N/A	0.003%
5/21/2026	Essential Partners LLC	12,527	$0.54M	0.2%	-48.5%	0.005%
5/21/2026	BankChampaign National Association	14,901	$0.64M	0.6%	N/A	0.006%
5/19/2026	Western Wealth Management LLC	673	$29K	0.0%	N/A	0.000%
5/19/2026	Winnow Wealth LLC	19,700	$0.85M	0.7%	-6.7%	0.008%
5/19/2026	Ariadne Wealth Management LP	5,181	$0.22M	0.1%	-18.1%	0.002%
5/19/2026	Bank of America Corp DE	1,644,737	$70.54M	0.0%	-26.0%	0.654%
5/19/2026	Edgestream Partners L.P.	174,455	$7.48M	0.2%	+21.1%	0.069%
5/19/2026	Janus Henderson Group PLC	913,802	$39.20M	0.0%	+44.2%	0.364%
5/19/2026	Cim LLC	35,969	$1.54M	0.2%	-1.0%	0.014%
5/19/2026	Bull Harbor Capital LLC	21,258	$0.91M	0.2%	N/A	0.008%
5/19/2026	Strategic Investment Advisors MI	46,921	$2.01M	0.1%	+48.4%	0.019%
5/19/2026	Arkadios Wealth Advisors	11,098	$0.48M	0.0%	N/A	0.004%
5/18/2026	Amundi	34,398	$1.48M	0.0%	-77.9%	0.014%
5/18/2026	EverSource Wealth Advisors LLC	11,015	$0.47M	0.0%	-11.2%	0.004%
5/18/2026	Talon Private Wealth LLC	14,896	$0.64M	0.1%	N/A	0.006%
5/18/2026	California State Teachers Retirement System	297,156	$12.75M	0.0%	+22.3%	0.118%
5/18/2026	Royal Bank of Canada	694,131	$29.77M	0.0%	+24.6%	0.276%
5/18/2026	Empowered Funds LLC	335,606	$14.39M	0.1%	+37.6%	0.134%
5/16/2026	The Manufacturers Life Insurance Company	184,117	$7.90M	0.0%	-5.3%	0.073%
5/16/2026	Quantinno Capital Management LP	115,592	$4.96M	0.0%	+44.3%	0.046%
5/16/2026	Lazard Asset Management LLC	372,600	$15.98M	0.0%	+15.2%	0.148%
5/15/2026	Gateway Wealth Partners LLC	15,223	$0.65M	0.0%	N/A	0.006%
5/15/2026	Weiss Asset Management LP	11,580	$0.50M	0.0%	N/A	0.005%
5/15/2026	OMERS ADMINISTRATION Corp	88,362	$3.79M	0.0%	+27.0%	0.035%
5/15/2026	Rice Hall James & Associates LLC	16,826	$0.72M	0.0%	-16.5%	0.007%
5/15/2026	Van Diest Capital LLC	9,625	$0.41M	0.3%	+24.1%	0.004%
5/15/2026	Waverly Advisors LLC	12,665	$0.54M	0.0%	-4.2%	0.005%
5/15/2026	Dempze Nancy E	18,500	$0.79M	0.4%	-5.1%	0.007%
5/15/2026	Entropy Technologies LP	107,851	$4.63M	0.2%	+342.6%	0.043%
5/14/2026	Healthcare of Ontario Pension Plan Trust Fund	438,000	$18.79M	0.0%	-1.8%	0.174%
5/14/2026	Renaissance Technologies LLC	13,726,993	$588.75M	0.9%	-1.3%	5.461%
5/14/2026	Public Employees Retirement System of Ohio	104,570	$4.49M	0.0%	-0.8%	0.042%
5/14/2026	Compound Planning Inc.	5,982	$0.26M	0.0%	N/A	0.002%
5/14/2026	Arrowstreet Capital Limited Partnership	4,834,625	$207.36M	0.1%	-8.4%	1.923%
5/14/2026	Oak Associates Ltd. OH	72,264	$3.10M	0.2%	-8.2%	0.029%
5/14/2026	Caxton Associates LLP	5,235	$0.23M	0.0%	-28.0%	0.002%
5/14/2026	Systematic Financial Management LP	709,127	$30.42M	0.7%	-28.2%	0.282%
5/14/2026	Sei Investments Co.	1,629,670	$69.90M	0.1%	-8.6%	0.648%
5/14/2026	Lido Advisors LLC	5,829	$0.25M	0.0%	N/A	0.002%
5/14/2026	State of Wyoming	9,524	$0.41M	0.0%	+17.9%	0.004%
5/13/2026	Cetera Investment Advisers	169,881	$7.29M	0.0%	+17.4%	0.068%
5/13/2026	Measured Wealth Private Client Group LLC	784	$34K	0.0%	-85.7%	0.000%
5/13/2026	Signature Equity Partners LLC	3,114	$0.13M	0.1%	+55.2%	0.001%
5/13/2026	NewEdge Wealth LLC	42,331	$1.82M	0.0%	+49.7%	0.017%
5/13/2026	First Trust Advisors LP	2,534,992	$108.73M	0.1%	+62.0%	1.009%
5/8/2026	PNC Financial Services Group Inc.	19,896	$0.85M	0.0%	-3.3%	0.008%
5/8/2026	Cassaday & Co Wealth Management LLC	625	$27K	0.0%	N/A	0.000%
5/8/2026	Convergence Investment Partners LLC	69,616	$2.99M	0.5%	+44.2%	0.028%
5/7/2026	Earned Wealth Advisors LLC	7,283	$0.31M	0.0%	-12.0%	0.003%
5/7/2026	Dimensional Fund Advisors LP	4,299,597	$184.39M	0.0%	+0.9%	1.693%
5/7/2026	Balefire LLC	7,022	$0.30M	0.1%	-5.4%	0.003%
5/7/2026	Parallel Advisors LLC	9,115	$0.39M	0.0%	+5.7%	0.004%
5/7/2026	KBC Group NV	45,472	$1.95M	0.0%	+2.8%	0.018%
5/7/2026	Precision Wealth Strategies LLC	13,476	$0.58M	0.2%	N/A	0.005%
5/7/2026	AIA Group Ltd	10,432	$0.45M	0.0%	-23.4%	0.004%
5/6/2026	IMA Advisory Services Inc.	94,710	$4.06M	0.4%	-4.8%	0.037%
5/6/2026	California Public Employees Retirement System	555,750	$23.84M	0.0%	+7.1%	0.219%
5/6/2026	Arcus Capital Partners LLC	5,876	$0.25M	0.1%	-22.0%	0.002%
5/6/2026	Assetmark Inc.	3,388,920	$145.35M	0.3%	+1.7%	1.334%
5/6/2026	Gallacher Capital Management LLC	17,013	$0.73M	0.3%	+35.2%	0.007%
5/6/2026	Financiere des Professionnels Fonds d investissement inc.	37,008	$1.59M	0.1%	+28.4%	0.015%
5/6/2026	Bessemer Group Inc.	1,972	$85K	0.0%	+36.8%	0.001%
5/6/2026	Allspring Global Investments Holdings LLC	1,707,715	$75.21M	0.1%	+23.4%	0.672%
5/5/2026	Westover Capital Advisors LLC	89,009	$3.82M	0.7%	+3.0%	0.035%
5/5/2026	Bank of New York Mellon Corp	1,986,035	$85.18M	0.0%	-2.8%	0.782%
5/5/2026	Illinois Municipal Retirement Fund	215,698	$9.25M	0.1%	+12.2%	0.085%
5/5/2026	Three Seasons Wealth LLC	59,519	$2.55M	1.0%	+345.6%	0.023%
5/5/2026	Harel Insurance Investments & Financial Services Ltd.	41,748	$1.79M	0.0%	-28.2%	0.016%
5/5/2026	Sanctuary Advisors LLC	74,269	$3.19M	0.0%	+11.5%	0.029%
5/5/2026	Nwam LLC	5,802	$0.25M	0.0%	-6.8%	0.002%
5/5/2026	Hillsdale Investment Management Inc.	99,800	$4.28M	0.1%	+4.1%	0.039%
5/4/2026	Canal Insurance CO	20,000	$0.86M	0.2%	N/A	0.008%
5/4/2026	State of Michigan Retirement System	62,516	$2.68M	0.0%	-1.3%	0.025%
5/4/2026	Principal Financial Group Inc.	583,744	$25.04M	0.0%	+1.5%	0.230%
5/4/2026	Chicago Partners Investment Group LLC	16,204	$0.76M	0.0%	+2.8%	0.006%
5/4/2026	Arbejdsmarkedets Tillaegspension	609,492	$26.14M	0.7%	+9.7%	0.240%
5/1/2026	Commonwealth of Pennsylvania Public School Empls Retrmt SYS	65,071	$2.79M	0.0%	-3.0%	0.026%
5/1/2026	Citizens Financial Group Inc. RI	6,605	$0.28M	0.0%	N/A	0.003%
5/1/2026	Fifth Third Bancorp	69,836	$3M	0.0%	+1,938.4%	0.027%
5/1/2026	Candriam S.C.A.	143,557	$6.16M	0.0%	-50.0%	0.057%
5/1/2026	Sequoia Financial Advisors LLC	12,704	$0.55M	0.0%	-26.8%	0.005%
4/30/2026	Hsbc Holdings PLC	65,978	$2.84M	0.0%	+152.9%	0.026%
4/30/2026	Roman Butler Fullerton & Co.	15,277	$0.68M	0.2%	N/A	0.006%
4/30/2026	Kestra Advisory Services LLC	16,967	$0.73M	0.0%	-12.0%	0.007%
4/30/2026	Sumitomo Mitsui Trust Group Inc.	59,420	$2.55M	0.0%	+0.5%	0.023%
4/30/2026	Greenwood Capital Associates LLC	8,447	$0.36M	0.0%	-4.7%	0.003%
4/29/2026	Childress Capital Advisors LLC	4,800	$0.21M	0.0%	N/A	0.002%
4/29/2026	Flatrock Wealth Partners LLC	6,289	$0.27M	0.1%	N/A	0.002%
4/29/2026	Jackson Thornton Wealth Management LLC	6,578	$0.29M	0.0%	-33.3%	0.003%
4/29/2026	Resonant Capital Advisors LLC	14,144	$0.61M	0.0%	-5.0%	0.006%
4/29/2026	Burney Co.	135,207	$5.80M	0.2%	-33.9%	0.053%
4/28/2026	Cypress Capital LLC	15,723	$0.67M	0.2%	-5.5%	0.006%
4/28/2026	Marietta Investment Partners LLC	8,944	$0.38M	0.1%	-51.9%	0.004%

Data available starting January 2016

Exelixis, Inc., an oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States. The company offers CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ capsules for the treatment of progressive and metastatic medullary thyroid cancer. Its CABOMETYX and COMETRIQ are derived from cabozantinib, an inhibitor of multiple tyrosine kinases, including MET, AXL, RET, and VEGF receptors. The company also offers COTELLIC, an inhibitor of MEK as a combination regimen to treat specific forms of advanced melanoma; and MINNEBRO, an oral non-steroidal selective blocker of the mineralocorticoid receptor for the treatment of hypertension in Japan. It develops zanzalintinib, a novel, potent, next-generation oral tyrosine kinase inhibitor (TKI) that targets VEGF receptors, MET and the TAM kinases (TYRO3, AXL and MER); and XB002, a next-generation tissue factor (TF)-targeting ADC, administered via intravenous infusion and composed of a human monoclonal antibody (mAb) against TF that is conjugated to an auristatin-based microtubulin inhibitor (MTI) payload. It has research collaborations and license agreements with Ipsen Pharma SAS; Takeda Pharmaceutical Company Ltd.; F. Hoffmann-La Roche Ltd.; Redwood Bioscience, Inc.; R.P. Scherer Technologies, LLC; Catalent Pharma Solutions, Inc.; NBE Therapeutics AG; Aurigene Discovery Technologies Limited; Iconic Therapeutics, Inc.; Invenra, Inc.; StemSynergy Therapeutics, Inc.; Genentech, Inc.; Bristol-Myers Squibb Company; and Daiichi Sankyo Company, Limited, as well as clinical development agreement with Sairopa B.V. for ADU-1805. The company was formerly known as Exelixis Pharmaceuticals, Inc. and changed its name to Exelixis, Inc. in February 2000. Exelixis, Inc. was incorporated in 1994 and is headquartered in Alameda, California.

Today's Range

Now: $51.91

$50.96

$53.12

50 Day Range

MA: $48.66

$43.61

$53.50

52 Week Range

Now: $51.91

$33.76

$53.93

Volume

6,545,158 shs

Average Volume

2,152,749 shs

Market Capitalization

$13.05 billion

P/E Ratio

17.25

Dividend Yield

N/A

Beta

0.41

Who are the company insiders with the largest holdings of Exelixis?: Exelixis' top insider shareholders include:
George A Scangos (Director)
David Edward Johnson (Director)
Stelios Papadopoulos (Director)
Christopher J Senner (CFO)
Michael Morrissey (CEO)
Jeffrey Hessekiel (EVP)
Dana Aftab (EVP)
Lance Willsey (Director)
Patrick J Haley (EVP)
Amy C Peterson (CMO)
Learn More about top insider investors at Exelixis.
Who are the major institutional investors of Exelixis?: Exelixis' top institutional investors include:
Renaissance Technologies LLC — 5.46%
Arrowstreet Capital Limited Partnership — 1.92%
Dimensional Fund Advisors LP — 1.69%
Assetmark Inc. — 1.33%
First Trust Advisors LP — 1.01%
Stephens Investment Management Group LLC — 0.99%
Learn More about top institutional investors of Exelixis stock.
Which major investors are selling Exelixis stock?: During the previous quarter, EXEL stock was sold by these institutional investors:
Bank of America Corp DE
Arrowstreet Capital Limited Partnership
Systematic Financial Management LP
Renaissance Technologies LLC
Sei Investments Co.
Candriam S.C.A.
Amundi
Burney Co.
Within the previous year, company insiders that have sold Exelixis company stock include:
Stelios Papadopoulos (Director)
Christopher J Senner (CFO)
Dana Aftab (EVP)
Patrick J Haley (EVP)
Jack L Wyszomierski (Director)
George Poste (Director)
Brenda Hefti (SVP)
Maria C Freire (Director)
Mary C Beckerle (Director)
Bob Oliver (Director)
Sue Gail Eckhardt (Director)
Learn More investors selling Exelixis stock.
Which major investors are buying Exelixis stock?: In the previous quarter, EXEL stock was acquired by institutional investors including:
First Trust Advisors LP
Allspring Global Investments Holdings LLC
Janus Henderson Group PLC
Pictet Asset Management Holding SA
Royal Bank of Canada
BI Asset Management Fondsmaeglerselskab A S
Empowered Funds LLC
Entropy Technologies LP